Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine
胰腺癌的个性化临床前模型:一种易于处理的精准医疗方法
基本信息
- 批准号:10372089
- 负责人:
- 金额:$ 26.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAftercareAwardBasic ScienceBiological MarkersBiologyBiopsyCancer BiologyCancer CenterCancer EtiologyCaringCell LineCessation of lifeChemotherapy and/or radiationClinicClinicalClinical OncologyClinical ResearchClinical TreatmentClinical TrialsClinical Trials DesignColon CarcinomaCombined Modality TherapyComprehensive Cancer CenterCulture TechniquesCytotoxic ChemotherapyDataDevelopmentDevelopment PlansDiagnosisDiseaseDisease modelEnvironmentExcisionExposure toExtramural ActivitiesFosteringFoundationsFundingFutureGene ExpressionGene Expression ProfileGene Expression ProfilingGeneticGenotypeGleanGoalsGuidelinesHeterogeneityImageImmuneImmunotherapyIn VitroIndividualInstitutesInstitutionK-Series Research Career ProgramsKnowledgeLaboratoriesLeadershipLifeLosartanMalignant neoplasm of pancreasMentorsMentorshipMethodsMicrosatellite InstabilityModelingMolecularNewly DiagnosedNivolumabOperating RoomsOperative Surgical ProceduresOrganoidsOutcomePancreatic Ductal AdenocarcinomaPatient-Focused OutcomesPatientsPersonsPharmaceutical PreparationsPhasePhase II Clinical TrialsPre-Clinical ModelPrecision medicine trialPrecision therapeuticsPrimary NeoplasmRadiationRadiation therapyRandomizedRecommendationRecording of previous eventsRecurrenceResearchResearch PersonnelResearch TrainingResectableResectedResourcesRoleSafetyScienceScientistSpeedSurgeonSurgical OncologySystemic TherapyTestingTherapeuticTimeTranslational ResearchUnited StatesUniversitiesUnresectableWorkadvanced diseasebasecancer carecareer developmentchemotherapyclinically actionableclinically relevantdesigndrug sensitivityexperiencefour-arm trialhormone therapyimmunohistochemical markersimprovedmalignant breast neoplasmmolecular markernovelnovel therapeuticsoperationpatient derived xenograft modelpatient orientedpatient screeningpersonalized therapeuticprecision medicineprogramsrecruitresponsetooltranslational cancer researchtreatment responsetreatment strategytumortumor heterogeneitytwo-dimensional
项目摘要
Project Summary/Abstract
Built upon a history of sustained commitment to becoming a clinician scientist, the goal of this proposal is
to become an independent investigator and leader in the field of translational cancer research and molecularly-
guided precision medicine trials in pancreatic ductal adenocarcinoma (PDAC). PDAC impacts over 50,000
people annually in the United States and will soon become the second leading cause of cancer-related death.
Two tractable strategies to increase survival in this devastating disease are: (1) to increase the utilization of
potentially curative surgical resection, and (2) to identify the optimal systemic therapy for each patient amongst
the cadre of agents currently prescribed in the clinic. To evaluate these strategies, this proposal is based upon
a multi-center, randomized, phase II clinical trial investigating the safety and efficacy of an aggressive surgical
approach to borderline resectable and locally advanced disease after combination cytotoxic chemotherapy,
radiation, and immunotherapy. In the context of this trial, we will also evaluate the capacity of a novel culture
technique, termed organoids, to provide clinically-actionable molecular data and guide precision medicine
approaches. Taken together, this proposal evaluates a treatment strategy that may result in a curative
operation for an additional 20-40% of newly diagnosed PDAC patients (10 - 20,000 US citizens annually) and
will evaluate a tool for selection of best systemic therapy for each PDAC patient to provide a durable survival.
To foster a transition to independence and enable leadership in future projects, translational research
efforts will be supplemented during the award period with a formal career development plan. This plan is
guided by the mentorship of Dr. Elizabeth Jaffee, a renowned leader in the field of translational research in
PDAC and the deputy director of the Comprehensive Cancer Center at Johns Hopkins University (JHU). As an
extramurally-funded researcher with an expertise in immune-focused and molecularly-guided clinical trials, Dr.
Jaffee is an ideal mentor. An advisory committee has been established to include the world’s leading expert in
PDAC organoids, Dr. David Tuveson, and a leader in surgical science initiatives, Dr. Christopher Wolfgang. I
have joined the Division of Surgical Oncology as a surgeon-scientist with 75% protected research time. The
research and training plan will be completed at JHU, one of the world’s leading institutions for pancreatic
cancer care and a top-ranked research institution. In the rich environment and resources of JHU, I will pursue
didactic coursework in the design and conduct of novel translational research and clinical trials. To reach
independence as a surgeon-scientist, I will also draw upon the resources of a formal K-to-R transition program
administered by the JHU Institute for Clinical and Translational Research. Support through the K08 Career
Development Awards Program will be critical in helping me to achieve a long-term goal of serving as a leader
in molecularly-guided precision medicine trials that have the potential to redefine outcomes in PDAC.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Andrew Burkhart其他文献
Richard Andrew Burkhart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Andrew Burkhart', 18)}}的其他基金
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine
胰腺癌的个性化临床前模型:一种易于处理的精准医疗方法
- 批准号:
10591500 - 财政年份:2020
- 资助金额:
$ 26.27万 - 项目类别:
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine
胰腺癌的个性化临床前模型:一种易于处理的精准医疗方法
- 批准号:
10115679 - 财政年份:2020
- 资助金额:
$ 26.27万 - 项目类别:
相似海外基金
Life outside institutions: histories of mental health aftercare 1900 - 1960
机构外的生活:1900 - 1960 年心理健康善后护理的历史
- 批准号:
DP240100640 - 财政年份:2024
- 资助金额:
$ 26.27万 - 项目类别:
Discovery Projects
Development of a program to promote psychological independence support in the aftercare of children's homes
制定一项计划,促进儿童之家善后护理中的心理独立支持
- 批准号:
23K01889 - 财政年份:2023
- 资助金额:
$ 26.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:
10452217 - 财政年份:2022
- 资助金额:
$ 26.27万 - 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:
10670838 - 财政年份:2022
- 资助金额:
$ 26.27万 - 项目类别:
Aftercare for young people: A sociological study of resource opportunities
年轻人的善后护理:资源机会的社会学研究
- 批准号:
DP200100492 - 财政年份:2020
- 资助金额:
$ 26.27万 - 项目类别:
Discovery Projects
Creating a National Aftercare Strategy for Survivors of Pediatric Cancer
为小儿癌症幸存者制定国家善后护理策略
- 批准号:
407264 - 财政年份:2019
- 资助金额:
$ 26.27万 - 项目类别:
Operating Grants
Aftercare of green infrastructure: creating algorithm for resolving human-bird conflicts
绿色基础设施的善后工作:创建解决人鸟冲突的算法
- 批准号:
18K18240 - 财政年份:2018
- 资助金额:
$ 26.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an aftercare model for children who have experienced invasive procedures
为经历过侵入性手术的儿童开发善后护理模型
- 批准号:
17K12379 - 财政年份:2017
- 资助金额:
$ 26.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a Comprehensive Aftercare Program for children's self-reliance support facility
为儿童自力更生支持设施制定综合善后护理计划
- 批准号:
17K13937 - 财政年份:2017
- 资助金额:
$ 26.27万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Project#2 Extending Treatment Effects Through an Adaptive Aftercare Intervention
项目
- 批准号:
8742767 - 财政年份:2014
- 资助金额:
$ 26.27万 - 项目类别:














{{item.name}}会员




